Vaxcyte, Inc. (PCVX) operating KPIs

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 7/30

$62.03−0.58 (-0.93%)

Close on Oct 30, 2026Market cap $9.23BP/E –Yield 0.00%

KPIs

Operating metrics that drive Vaxcyte's business

Coming soon

This tab will track the numbers specific to Vaxcyte's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.